Overview
- Media outlets published explanatory pieces on Tuesday, May 26, that identified the common upper-arm mark as the expected local result of the neonatal BCG vaccine and reiterated official guidance.
- The scar forms because BCG is given intradermally and produces a small local reaction that can progress from a nodule to a pustule or crust and then heal by scarring.
- The Ministry of Health recommends a single BCG dose for newborns and says that dose is sufficient whether or not a visible scar develops, so caregivers should check vaccination records rather than the mark.
- Typical scars are small and circular, about 3–10 millimeters, usually on the upper right arm, and may fade or persist without needing treatment.
- Care is advised only for signs of a problematic reaction in recently vaccinated infants such as high fever, heavy persistent discharge, marked local inflammation, intense pain, or very enlarged lymph nodes, and the BCG has long been used across Latin America to prevent severe pediatric forms of tuberculosis.